Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
주식 순위 #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
주가
$0.83030862
마지막 동기화: 2024-06-27
시가총액
$726.64K
변동 (1일)
-1.35%
변동 (1년)
0.00%
국가
DE
거래 Epigenomics AG (ECX)

카테고리

Epigenomics AG (ECX)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Epigenomics AG의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Epigenomics AG의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
4.61 -
US
5.46 -
US
- -
CN
9.92 -
US
15.33 -
US